Appili Therapeutics Inc
OTC: APLIF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Don Cilla
- Employees
- 7
- Headquarters
- Halifax, Canada
- IPO year
- 2021
- Market cap
- $1.0M
- Website
- http://www.appilitherapeutics.com
Loading APLIF…
Loading profile data…Frequently asked questions about APLIF
What does Appili Therapeutics Inc (APLIF) do?
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in H...
Where does APLIF trade?
Appili Therapeutics Inc (APLIF) trades on the Other OTC.
What sector is APLIF in?
Appili Therapeutics Inc (APLIF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Appili Therapeutics Inc?
Don Cilla is the chief executive officer of Appili Therapeutics Inc (APLIF).
Where is Appili Therapeutics Inc headquartered?
Appili Therapeutics Inc is headquartered in Canada.
Does APLIF pay a dividend?
Appili Therapeutics Inc (APLIF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APLIF go public?
Appili Therapeutics Inc (APLIF) completed its initial public offering in 2021.